This MedLibrary.org supplementary page on Ecothiopate is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
 |
|
|
Ecothiopate iodide
|
|
| Systematic (IUPAC) name | |
| 2-diethoxyphosphorylsulfanylethyl-trimethyl-ammonium iodide | |
| Identifiers | |
| CAS number | |
| ATC code | S01 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C9H23INO3PS |
| Mol. mass | 383.228 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | Topical (eye drops) |
Ecothiopate iodide (INN, also known as echothiophate) is a parasympathomimetic and organophosphate. It is a cholinesterase inhibitor.1
Uses
It is used as an ocular antihypertensive in the treatment of chronic glaucoma and, in some cases, accommodative esotropia. It is available under several trade names such as Phospholine Iodide (Wyeth-Ayerst).
Ecothiopate binds irreversibly to cholinesterase. Because of the very slow rate at which echothiophate is hydrolyzed by cholinesterase, its effects can last a week or more. Adverse effects include muscle spasm and other systemic effects.
Shortage
Wyeth Pharmaceuticals stopped manufacturing ecothiopate iodide (phospholine iodide) in the US in 2003. After contacting the American Academy of Ophthalmology (AAO), Wyeth rescinded their decision and, according to AAO public relations representative Michelle Stephens, the AAO and Wyeth were in talks for about a year about manufacturing it. 2
In the meantime, a worldwide shortage of the drug has occurred.
Sources
- ^ Gabelt BT, Hennes EA, Seeman JL, Tian B, Kaufman PL (August 2004). "H-7 effect on outflow facility after trabecular obstruction following long-term echothiophate treatment in monkeys". Invest. Ophthalmol. Vis. Sci. 45 (8): 2732–6. doi:. PMID 15277498. http://www.iovs.org/cgi/pmidlookup?view=long&pmid=15277498.
- ^ Eurotimes article: "Echothiophate iodide shortage leaves US specialists struggling to find alternative for acute cases"
- Brenner, G. M. (2000). Pharmacology. Philadelphia, PA: W.B. Saunders Company. ISBN 0-7216-7757-6.
- Canadian Pharmacists Association (2000). Compendium of Pharmaceuticals and Specialties (25th ed.). Toronto, ON: Webcom. ISBN 0-919115-76-4.
- Rang, H. P. (2003). Pharmacology. Edinburgh: Churchill Livingstone, p. 146. ISBN 0-443-07145-4.
|
|||||||||||||
|
||||||||||||||||||||
Wikipedia content modification information:
- This page was last modified on 29 September 2008, at 12:52.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Ecothiopate".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.